仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Actoxumab （Anti-C. difficile Toxin A Recombinant Antibody） is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab （HY-P9929） targeting TcdB